disitamab vedotin fda approval

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
disitamab vedotin fda approval	1.02	0.3	5990	11	30
disitamab	1.16	0.1	8480	32	9
vedotin	0.89	1	9196	3	7
fda	1	1	4484	11	3
approval	1.98	0.2	1774	65	8

Keyword	CPC	PCC	Volume	Score
disitamab vedotin fda approval	1.41	0.5	2820	92
disitamab vedotin for injection	1.32	1	6611	77
disitamab vedotin clinical trials	1.37	0.4	8845	80
tisotumab vedotin fda approval	1.5	0.4	4464	99
brentuximab vedotin fda approval	0.69	0.9	1891	54
disitamab-vedotin	0.24	0.9	2390	60
polatuzumab vedotin fda approval	0.09	0.6	9464	35
tisotumab vedotin fda label	0.71	0.8	4332	81
telisotuzumab vedotin fda approval	1.28	0.1	938	41
polatuzumab vedotin fda approval history	0.93	0.6	6590	78
enfortumab vedotin fda approval	1.84	0.2	5005	22
enfortumab vedotin fda approval history	1.27	1	61	19
brentuximab vedotin fda label	1.54	0.9	5774	19
disitamab vedotin gastric cancer	1.38	0.1	9203	66
disitamab vedotin bladder cancer	0.64	0.8	6543	72
tisotumab vedotin ema approval	1.85	0.4	5206	16
polatuzumab vedotin fda label	0.54	1	969	5
enfortumab vedotin fda label	1.99	0.8	8995	50
brentuximab vedotin and fda indications	1.89	0.5	9441	3